Clinical Observation of Pemetrexed Plus Carboplatin Chemotherapy as Treatment of EGFR-TKI Resistant and No-mutated in Advanced Lung Adenocarcinoma

QI Yanyu; ZHANG Jun; JIANG Shasha; ZHOU Congming

doi:10.14033/j.cnki.cfmr.2021.31.016

Home>Articles>Clinical Observation of Pemetrexed Plus Carboplatin Chemotherapy as Treatment of EGFR-TKI Resistant and No-mutated in Advanced Lung Adenocarcinoma

DOI: 10.14033/j.cnki.cfmr.2021.31.016

Clinical Observation of Pemetrexed Plus Carboplatin Chemotherapy as Treatment of EGFR-TKI Resistant and No-mutated in Advanced Lung Adenocarcinoma

QI Yanyu

ZHANG Jun

JIANG Shasha

ZHOU Congming

Machine-generated Keywords：

Publication Date：2021-11-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 59-63 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2021,19(31)